baber/WOPTO huggingface dataset:
Patent EP-1630105-A2 (EP)
Inventor: SCHUETZ UDO
IPC: B29C65/20
Filed: 2005-08-06
Abstract: Producing plastic tanks for liquids involves producing the tanks from a tubular parison by blow molding, where a holding flange or a threaded socket is formed on a rear section of a lower recess of the tank front wall, which recess receives a tapping valve; cutting out the recess of the tanks inside the holding flange or the threaded socket; and welding the finished preassembled tapping valve to the holding flange or threaded socket. Producing plastic tanks for liquids, especially for use as inner tanks for liquid shipping and storage tanks with an outer jacket in the form of a cage or sheet material and a pallet-like support frame, which are constructed as rectangular-solid or cubic tanks with four sidewalls, an upper base with a filling socket that can be closed with a cap, a lower base, and a drain outlet in the lower section of a sidewall for connection to a tapping valve (10), involves: (A) producing the tanks (2)from a tubular parison by blow molding, where a holding flange (19) or a threaded socket is formed on the rear section (21) of a lower recess (12) of the front wall of the tank, which recess receives the tapping valve; (B) cutting out the recess of the tanks inside the holding flange or the threaded socket with a cutting tool to produce the drain outlet of the tanks; and (C) welding the finished preassembled tapping valve to the holding flange or threaded socket in a welding machine.
Patent EP-1635051-A2 (EP)
Inventor: KAMADA SEIJI
IPC: F02B77/02
Filed: 2005-09-08
Abstract: A member for an internal combustion engine, such as a piston, a valve and a fuel injection valve. The member includes a substrate. A carbon-based coating film is formed on the substrate to cover at least a part of a region of the substrate to which region fuel for the internal combustion engine is contactable. The carbon-based coating film contains fluorine and has a thickness of 10 µm or less.
Patent EP-1655686-A2 (EP)
Inventor: RICHTER MICHAEL
IPC: G06K7/00
Filed: 2005-10-13
Abstract: The device (10) has a contact holder (11) for accommodating contact units that connect contacts of a smart card (12) with conducting paths of a circuit carrier e.g. printed circuit board. A plate shaped cover (13) fixed at the contact holder. A front edge area of the cover is arranged in their base level in an elastically movable manner. A section of the cover is designed as a spring elastic guide.
Patent EP-1659340-A2 (EP)
Inventor: HESS KRISTOFFER
IPC: F24B1/18
Filed: 2005-11-17
Abstract: A simulated fuel bed for simulating a combustible fuel in an artificial fire. The simulated fuel bed includes a plurality of simulated combustible fuel elements, including one or more light-producing simulated combustible fuel elements. A body of the light-producing simulated combustible fuel element has one or more cavities therein, and one or more light sources positioned to direct light therefrom inside the cavity. The body includes an exterior surface and one or more light-transmitting parts extending between the cavity and the exterior surface. The light-transmitting part is positioned in a path of light from the light source. The light from the light source is transmittable through the light-transmitting part to the exterior surface for simulating glowing embers of the combustible fuel.
Patent EP-1642944-A2 (EP)
Inventor: CAIGER NIGEL ANTONY
IPC: C09D11/00
Filed: 1999-04-21
Abstract: A vehicle for a hot melt ink-jet ink comprises at least 30 % by weight of a radiation curable material and a thickener. The vehicle is a thixotropic paste at 20°C, preferably also at 25°C and has viscosity of less than 25 centipoise, preferably 12 centipoise at at least one temperature in the range of from 40°C to 130°C. Another vehicle for a hot melt ink-jet ink comprises a radiation curable material. The curable material is a paste or a solid at 20°C, preferably also at 25°C and has a viscosity of less than 25 centipoise, preferably 12 centipoise at at least one temperature in the range of from 40°C to 130°C.
Patent EP-1679335-A2 (EP)
Inventor: FERENZ MICHAEL DR
IPC: C09K23/00
Filed: 2005-12-20
Abstract: Preparation of organopolysiloxane (A) comprises adding organopolysiloxane (I) (6-folds molecular excess) with vinylsiloxane (II) in the presence of platinum/rhodium catalyst; adding transition metal-catalyzed silicon hydride (SiH) groups of alkenyl/alkynyl compounds to the reaction product; and partially/completely reacting the RSiH groups (obtained from the above reaction) with at least an alcohol, in the presence of a catalyst. Preparation of organopolysiloxane (A) comprises adding organopolysiloxane of formula (I) (6-folds molecular excess) with vinylsiloxane (II) of formula (CH 2=CH-Si(R1 2)-O-[Si(R1 2)-O] d-Si(R1 2)-CH=CH 2) in the presence of platinum/rhodium catalyst; adding transition metal-catalyzed silicon hydride (SiH) groups of alkenyl/alkynyl compounds to the reaction product (where the remaining RSiH-groups with at least one alcohol, aromatic, aliphatic-aromatic, optionally halogen atoms of mono alcohols, polyethermonoalcohol, polyester mono alcohols or aminoalcohol); and partially/completely reacting the RSiH groups (obtained form the above reaction) with at least an alcohol from optionally saturated aromatic, aliphatic-aromatic, optionally halogen atom containing mono alcohols, polyethermonoalcohol, polyester monoalcohol or aminoalcohol, in the presence of a catalyst. R1 : H, or 1-20C aliphatic or aromatic hydrocarbon; R2 : H; a : 5-500; b : 1-50; c : 0-5 (preferably 0); and d : 10-1000. Provided that at least three residues of R1 and R2 are H. [Image].
Patent EP-1571203-A2 (EP)
Inventor: LALLI ALBERTO
IPC: A61K31/70
Filed: 2005-01-05
Abstract: The present invention relates to a cyanobacterium present in Euganean thermal
mud, to glycolipids with anti-inflammatory activity produced therefrom, to
medicaments comprising said glycolipids and to a maturation process suitable for
obtaining a thermal mud enriched with the aforesaid cyanobacterium.
Patent EP-1593439-A2 (EP)
Inventor: KUSTERMANN MARTIN
IPC: B05C11/04
Filed: 2005-03-14
Abstract: The device has a sealing doctor blade device (9) on the inlet side and a dosing doctor blade device (10) on the outlet side each with rotatable scraper blades (11, 12). The blade (12) of the dosing device has a higher permeability since it has a larger diameter than the blade of the sealing doctor blade device. The blades can have smooth or profiled surfaces. The blade of the sealing blade device turns at more than 50 revs per minute.
Patent EP-1642699-A2 (EP)
Inventor: ROTH MICHAEL
IPC: B29C48/85
Filed: 2005-09-07
Abstract: A plastics processing machine comprising at least one cylinder and a variable-speed screw with a profile designed to show approximately adiabatic behaviour, in which the output is determined by the speed of rotation.
Patent EP-1652619-A2 (EP)
Inventor: SCHNEIDER GUNTER
IPC: B24B13/02
Filed: 2005-10-20
Abstract: The tool has a drive shaft to drive a polishing pad (7) including a diaphragm (7.1). Force of the diaphragm is transferred perpendicularly to a lens surface by the polishing pad. The diaphragm is connected with a reinforcement unit (2), which is dimensionally stable and flexible in a direction parallel and perpendicular to a surface of the diaphragm. The unit is deformed by the pad into a toric form. An independent claim is also included for a method of operating an optical lens polishing tool.
Patent EP-1563935-A2 (EP)
Inventor: WATANABE NORIO
IPC: B23B19/02
Filed: 2005-02-10
Abstract: A tool holder (1) is attached to a spindle (2) by the
contacting of the projecting cone part (3) and end surface of
the tool holder with the recessed cone part and end surface of
the spindle respectively. A toroidal cone section (7) is
provided on the inner side surface of the recessed cone part
of the spindle so as to protrude inward. The diameter of the
toroidal cone section is formed smaller than the diameter of
the section of the projecting cone part of the tool holder
that abuts the toroidal cone section.
Patent EP-1577709-A2 (EP)
Inventor: TSUJI TOSHIHIKO
IPC: G02B5/30
Filed: 2005-03-17
Abstract: An illumination apparatus for illuminating a mask (200)
having a pattern, using light from a light source (102), includes
a generating section (140-152) for generating an effective light
source distribution for a modified illumination to the mask,
a polarization setting section (110) for setting a predetermined
polarization state in plural areas in the effective light
source distribution, and an adjusting section (160) for commonly
controlling a polarization state of each area.
Patent EP-1618862-A2 (EP)
Inventor: MANNIX SEAN
IPC: A61G12/00
Filed: 2005-07-21
Abstract: A transport cart (10) for attaching to a patient care apparatus (12), such as an infant care apparatus to move that infant care apparatus from one location to another. The transport cart is dockable to the infant care apparatus forming an overall footprint of the combination transport cart/infant care apparatus. The infant care apparatus has casters (24) to provide mobility thereto and the transport cart has a rearward portion with casters (30) and a forward portion that docks with the infant care apparatus that has a roller (38) that is rotatable about a fixed horizontal axis and, when the transport cart is docked to the infant care apparatus, the roller becomes located at or proximate to the center of the footprint of the combination transport cart/infant care apparatus. By the use of the centrally located roller, the user can more readily steer the combination apparatus by directing the rearward portion of the docking cart.
Patent EP-1730111-A2 (EP)
Inventor: BUCHSTALLER HANS-PETER
IPC: C07D409/12
Filed: 2005-01-17
Abstract: La présente invention a trait à des dérivés de bisarylurée de formule (I), à l'utilisation des composés de formule (I) en tant qu'inhibiteurs de la kinase RAF, à l'utilisation des composés de formule (I) pour la fabrication d'une composition pharmaceutique et à un procédé de traitement comprenant l'administration de ladite composition pharmaceutique à un patient.
Patent EP-1713543-A2 (EP)
Inventor: BADORC ALAIN
IPC: A61K31/437
Filed: 2005-02-04
Abstract: Use of 1, 2, 3 substituted indolizine derivatives (I) or their salts in the preparation of medicaments for the treatment of diseases related to the pathological choroid angiogenesis. Use of 1, 2, 3 substituted indolizine derivatives of formula (I) or their salts in the preparation of medicament for the treatment of diseases related to the pathological choroid angiogenesis R 1OH, 1-5C alkoxy, carboxy, 2-6C alcoxycarbonyl, -NR 5R 6, -NH-SO 2-Alk, -NH-SO 2-Ph, -NH-CO-Ph, -N(Alk)-CO-Ph, -NH-CO-NH-Ph, -NH-CO-Alk, -NH-CO 2-Alk, -O-(CH 2) n-cAlk, -O-Alk-COOR 7, -O-Alk-O-R 8, -O-Alk-OH, -O-Alk-C(NH 2):NOH, -O-Alk-NR 5R 6, -O-Alk-CN, -O-(CH 2) n-Ph, -O-Alk-CO-NR 5R 6, -CO-NH-(CH 2) m-COOR 7 or -CO-NH-Alk; Alk : 1-5C alkyl or 1-5C alkylene; cAlk : 3-6C cycloalkyl; R 5, R 6H, 1-5C alkyl or benzyl; R 7H or 1-5C alkyl; R 81-5C alkyl or -CO-Alk; Ph : phenyl (optionally substituted by one or more of halo, 1-5C alkoxy, carboxy or 2-6C alkoxycarbonyl); R 2H, 1-5C alkyl, 1-5C haloalkyl comprising 3-5 halogen atoms, 3-6C cycloalkyl or phenyl optionally substituted by one or more halo, 1-5C alkoxy, carboxy or 2-6C alkoxycarbonyl; A : -CO-, -SO- or -SO 2-; R 9, R 10H or 1-5C alkyl; R 11H or -Alk-COOR 12; R 12H, 1-5C alkyl or benzyl; HetN : heterocycle having 5 or 6 chains comprising at least one atom of N and optionally another heteroatom of N or O; either R 3, R 4H, 1-5C alkoxy, NH 2, carboxy, 2-6C alkoxycarbonyl, OH, NO 2, hydroxyamino, -Alk-COOR 7, -NR 5R 6, -NH-Alk-COOR 7, -NH-COO-Alk, -N(R 11)-SO 2-Alk-NR 9R 10, -N(R 11)-SO 2-Alk, -N(R 11)-Alk-NR 5R 6, -N(R 11)-CO-Alk-NR 9R 10, -N(R 11)-CO-Alk, -N(R 11)-CO-CF 3, -NH-Alk-HetN, -O-Alk-NR 9R 10, -O-Alk-CO-NR 5R 6 or -O-Alk-HetN; or R 3+R 4an unsaturated heterocycle having 5-6 chains (when R 3 is alkoxy, R 4 is -O-Alk-NR 9R 10 or OH, and R 1 does not represent an alkoxy); m : 1-5; and n : 0-5. [Image] ACTIVITY : Antiangiogenic; Ophthalmological; Antiinflammatory; Vasotropic. MECHANISM OF ACTION : Fibroblast growth factor inhibitor.
Patent EP-1729669-A2 (EP)
Inventor: GANLEY ROBERT
IPC: A61C8/00
Filed: 2005-03-11
Abstract: An implant abutment for attaching a dental prosthesis within a patient’s mouth is disclosed. The abutment includes a core and a cuff surrounding the core, and the color of the cuff is matched to the color of the prosthesis. Dental restoration systems and methods for fabricating a dental implant restoration utilizing the abutment are also disclosed.
Patent EP-1732483-A2 (EP)
Inventor: BEN YOUSSEF OUMEIMA
IPC: A61F5/455
Filed: 2005-03-31
Abstract: The invention relates to an external female incontinence device. The device comprises a flexible elastic strip having an opening in the strip, a fluid collection means surrounding the opening on one face, the strip and opening are sized and shaped so that when stretch fitted over the external urogenital organs the labia minor extends through the opening and a fluid tight fit between the upper face of the strip and the flesh surrounding the labia minora is formed. The device may further comprise a waistband for attachment of the device and to assist in maintaining a positive tension to press the device against the flesh surrounding the labia minora.
Patent EP-1735706-A2 (EP)
Inventor: JACKSON DAVID BRIAN
IPC: G06F9/50
Filed: 2005-03-11
Abstract: A system and method of co-allocating resources within a compute environment are disclosed. The method embodiment of the invention comprises receiving a request for a reservation for a first type of resource (Fig. 6, 602), analyzing constraints and guarantees associated with the first type of resource (604), identifying a first group of resources that meet the request for the first type of resource and storing in a first list (606), receiving a request for a reservation for a second type of resource (608), analyzing constraints and guarantees associated with the second type of resource (610), identifying a second group of resources that meet the request for the second type of resource and storing in a second list (612), calculating a co-allocation parameter between the first group of resources and the second group of resources and reserving resources according to the calculated co-allocation parameter of the first group of resources and the second group of resources. The request may also request exclusivity of the reservation.
Patent EP-1819249-A2 (EP)
Inventor: CHAN HILLARY
IPC: A43B3/12
Filed: 2005-06-22
Abstract: Attache de fermoir susceptible d'être fixée sur la partie supérieure de la semelle intérieure d'une chaussure. L'attache de fermoir comprend des première et seconde parties d'encliquetage, dont une est fixée sur la partie supérieure et l'autre sur la semelle. La partie fixée sur la semelle intérieure comprend un corps délimitant un évidement conçu pour recevoir par glissement la partie fixée sur la partie supérieure. L'évidement comporte une ouverture à travers laquelle la partie fixée sur la partie supérieure est apte à s'étendre. Le corps comporte une ligne centrale s'étendant à travers l'axe de l'évidement et le point médian de l'ouverture. Cette partie comporte également une base dotée d'une surface inférieure conçue pour être placée adjacente à la semelle d'usure. Le corps est fixé sur la base de telle sorte que la ligne centrale du corps forme un angle obtus avec le plan de la surface inférieure de la base. La base comporte une surface supérieure inclinée par rapport à la surface de base inférieure. L'attache de fermoir comporte également une détente à ressort montée sur une des parties de l'attache de fermoir. La détente coopère avec un évidement de réception de détente sur l'autre partie de l'attache de fermoir afin de maintenir les parties de l'attache de fermoir en position d'insertion totale.
Patent EP-1773408-A2 (EP)
Title: Colonoscopie virtuelle comprenant l'utilisation d'analogues d'ethers phospholipidiques radiomarques
Inventor: WEICHERT JAMEY P
IPC: A61K51/04
Filed: 2005-07-08
Abstract: La présente invention concerne des agents et des méthodes de colonoscopie virtuelle à double modalité permettant d'obtenir des informations anatomiques et fonctionnelles par balayage hybride CT/PET. Dans des modes de réalisation préférés, la présente invention concerne des agents radiomarqués spécifiques aux tumeurs et des méthodes permettant de distinguer les polypes bénins des tumeurs malignes. Dans d'autres modes de réalisation, la présente invention concerne des compositions et des méthodes utilisées pour distinguer les sous-régions morphologiques et fonctionnelles d'une région de tissu sélectionnée à partir des niveaux relatifs du métabolisme phospholipidique. Les agents radiomarqués spécifiques aux tumeurs préférés sont des analogues d'éthers phospholipidiques marqués à l'aide d'un radio-isotope halogène. Dans certains modes de réalisation préférés, les compositions contenant des analogues d'éthers phospholipidiques radiomarqués possèdent des actions thérapeutiques et permettent d'identifier d'un point de vue fonctionnel les tissus malins.
Patent EP-1781705-A2 (EP)
Inventor: CARDARELLI JOSEPHINE M
IPC: C07K16/28
Filed: 2005-06-20
Abstract: The present invention provides isolated human monoclonal antibodies that bind to IFNAR-1 and that are capable of inhibiting the biological activity of Type I interferons. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for inhibiting Type I interferon-mediated disorders using the antibodies of the invention, including methods for treating autoimmune disorders, transplant rejection or Graft Versus Host Disease using the antibodies of the invention.
Patent EP-1784942-A2 (EP)
Inventor: OBA YOSHIHIRO
IPC: H04K1/00
Filed: 2005-08-16
Abstract: L'invention concerne un système et un procédé pour l'établissement dynamique et sûr de tunnel pour dispositif mobile. Selon les modes de réalisation préférés, le système et le procédé décrits permettent d'attribuer de façon dynamique une ou plusieurs adresses d'extrémité de tunnel à un client qui n'est pas sur la même liaison IP qu'un agent d'authentification, selon un résultat d'authentification qui repose sur un numéro d'accès de source de protocole d'authentification, pour l'acheminement des communications.
Patent EP-1799268-A2 (EP)
Inventor: MYKHAYLYK OLGA
IPC: B82Y15/00
Filed: 2005-10-17
Abstract: Particles (I) for use in diagnosis and therapy, especially for binding with an active therapeutic agent, have a nanocrystalline magnetic core and an envelope enclosing the core. The core comprises at least 95 wt.% iron oxide and the specific saturation magnetization of the particle is at least 110 Am 2>/kg iron. Independent claims are also included for the following: (A) medicament or diagnostic agent containing (I); (B) preparation of magnetic particles for use in diagosis and therapy, particularly (I); (C) use of (I) for the manufacture of a medicament or in diagnosis, where (I) are bound to an active agent or a diagnostic agent, respectively. ACTIVITY : Cytostatic; Antibacterial; Antirheumatic; Anticonvulsant; Gynecological; Osteopathic; Vasotropic; Thrombolytic; Neuroprotective; Auditory; MECHANISM OF ACTION : None given.
Patent EP-1805514-A2 (EP)
Title: Immunodosages pour le topiramate
Inventor: OUYANG ANLONG
IPC: G01N33/53
Filed: 2005-10-21
Abstract: De manière générale, la présente invention concerne des analogues de topiramate qui ont des substituants au niveau du groupe sulfamate ou à la position 9 ou 10. Les analogues de topiramate peuvent comprendre des fractions immunogènes pouvant être utilisées pour préparer des anticorps anti-topiramate ou des fractions antigéniques pouvant être utilisées dans des dosages d'immunodiagnostic pour le topiramate. L'analogue de topiramate peut également comprendre des fractions traceur qui servent à détecter la présence ou la quantité de l'analogue au cours d'un dosage d'immunodiagnostic. De plus, les analogues de topiramate peuvent être utilisés dans des dosages d'immunodiagnostic pour concurrencer le topiramate au niveau de la liaison avec les anticorps anti-topiramate.
Patent EP-1814561-A2 (EP)
Title: Furopyrimidines et thienopyrimidines therapeutiques
Inventor: BABU YARLAGADDA S
IPC: A61P31/12
Filed: 2005-10-28
Abstract: L'invention concerne des composés de formules I, II, et III, ainsi que des compositions pharmaceutiques comprenant ces composés, et des procédés et des intermédiaires de synthèse qui permettent de préparer ces composés. On utilise les composés des formules I, II, et III comme agents antiviraux et/ou agents anticancéreux.
Patent EP-1825475-A2 (EP)
Inventor: SO KENNETH K
IPC: G11C5/06
Filed: 2005-11-29
Abstract: An apparatus is disclosed comprising a plurality of word lines and word line drivers, a plurality of bit lines and bit line drivers, and a plurality of memory cells coupled between respective word lines and bit lines. The apparatus also comprises circuitry operative to select a writing and/or reading condition to apply to a memory cell based on the memory cell's location with respect to one or both of a word line driver and a bit line driver. The apparatus can also comprise circuitry that is operative to select a number of memory cells to be programmed in parallel based on memory cell location with respect to a word line and/or bit line driver.
Patent EP-1742320-A2 (EP)
Inventor: KUROSAWA ATSUSHI
IPC: H02J1/12
Filed: 2006-07-07
Abstract: The present invention refers to a DC power source comprising a pair of terminals for outputting electric power; a first cell and a second cell connected to the pair of terminals in parallel; and an insulation type DC-DC converter connected to either one of the first cell or the second cell in series.
Patent EP-1703629-A2 (EP)
Inventor: STILLER ALEXANDER DR
IPC: H02P21/00
Filed: 2006-02-02
Abstract: The method involves performing current control with a pulse width modulated voltage, and determining the current actual value using a low pass filter. The phase offset of the low pass filter is less than a fiftieth of the period of the pulse width modulation. The sampling of the current actual value is synchronous to the period of the modulation defined by a switching signal, and a time offset of the signal occurs.
Patent EP-1729170-A2 (EP)
Inventor: CHEN YUNG-CHUAN
IPC: G03B3/10
Filed: 2006-05-12
Abstract: A camera module includes a lens (21), an actuator (25), a first magnetic device (22) and a second magnetic device (23). The actuator is for applying a driving force to move the lens. The first magnetic device is disposed on the lens. The second magnetic device is for interacting with the first magnetic device to generate a controlling force. The controlling force is reverse to the driving force in direction. When the actuator applies the driving force to move the lens, the controlling force provided by the second magnetic device serves as a controlling force for the lens moving.
Patent EP-1732075-A2 (EP)
Inventor: VAN SANTEN HELMAR
IPC: G11B7/12
Filed: 2003-11-20
Abstract: For irradiating a layer (5) a radiation beam (7) is directed and focussed to a spot (11) on the layer, relative movement of the layer relative to the optical element is caused so that, successively, different portions of the layer are irradiated and an interspace (53) between a surface of the optical element (59) nearest to the layer is maintained. Furthermore, at least a portion of the interspace through which the radiation irradiates the spot on the layer is maintained filled with a liquid, the liquid being supplied via a supply conduit (67) and flowing out of an outflow opening (90) through a total projected cross-sectional passage area in a plane parallel to the layer. The outflow opening or a plurality of the outflow openings are positioned such that, seen in a direction perpendicular to the layer, the total cross-sectional area has a centre in the portion of the interspace through which the radiation irradiates the spot.